The Surge on Wall Street, Short Sellers' Losses, and the Chance to Prevent Cancer: Where Is Moderna's Stock Heading?
The pharma stock that analysts bet against jumped 177% in one day, causing billions in losses for short sellers and forcing hedge funds to sell some of their best stocks. This happened following a successful…
Assessment
A single trading session erased billions from short sellers after Moderna's stock surged 177% on positive cancer vaccine trial results. The move forced hedge funds to liquidate other winning positions to cover losses, creating ripple effects across the market. The question no one is answering yet: does a promising early stage trial genuinely justify adding $30 billion in market value overnight, or is this momentum detached from fundamentals?